Tag: Home News
UNC Lineberger Comprehensive Cancer Center’s faculty were at the forefront of a many new efforts to fight, prevent and understand cancer in 2018. Projects launched or completed in the year included efforts to use the immune system to fight cancer, to better prevent cancer through screening, and to understand the disease at the most basic … Continued
UNC Lineberger’s Joshua Zeidner, MD, reported preliminary data at the 60th American Society of Hematology Annual Meeting from a phase II clinical trial for administering a high-dose of the chemotherapy treatment cytarabine followed by an immune checkpoint inhibitor, pembrolizumab, in patients with acute myeloid leukemia that had relapsed or no longer responded to other treatment.
The board, elected by ASCO’s member oncologists, is comprised of cancer physicians and clinical researchers who volunteer their time with ASCO. Basch is a medical oncologist and distinguished professor in the UNC School of Medicine Division of Hematology/Oncology and a professor in the UNC Gillings School of Global Public Health. He also is director of … Continued
There are many ways to show gratitude, but one patient took it to a new level, using her ties to the wedding industry and a tight-knit group of friends to hold an event to benefit ovarian cancer research and UNC Lineberger Comprehensive Cancer Center. With the help of her friends and daughter Terri Yates, Cindy … Continued
The Carolina Breast Cancer Study, UNC Lineberger’s landmark population-based study of breast cancer risk, biology, and outcomes that focuses on young and African-American women in North Carolina, recently celebrated the 10-year anniversary of its third phase. The study’s leadership hosted events this fall in Concord, Greenville and Cary to bring together and recognize the contributions of … Continued